ALXO Alx Oncology Holdings Inc.

Fundamentals / CIK 0001810182 / USD

Alx Oncology Holdings Inc. reported $154.7M in total assets and a net loss of $80.57M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ALXO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$21.71M$10.85M$0-$150.8MFY 2018 Revenue: $2.07MFY 2018 Net Income: -$13.73M2018FY 2019 Revenue: $4.80MFY 2019 Net Income: -$19.24M2019FY 2020 Revenue: $1.18MFY 2020 Net Income: -$45.74M2020FY 2021 Revenue: $0FY 2021 Net Income: -$83.46M2021FY 2022 Revenue: $0FY 2022 Net Income: -$123.5M2022FY 2023 Net Income: -$160.8M2023FY 2024 Net Income: -$134.8M2024FY 2025 Net Income: -$101.7M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $0 $0 $1.18M $4.80M $2.07M
Research & Development $77.00M $116.4M $141.8M $98.40M $60.17M $28.96M $16.31M $11.27M
Total Operating Expenses $104.0M $142.5M $170.3M $127.4M $83.56M $44.84M $23.98M $15.75M
Operating Income -$104.0M -$142.5M -$170.3M -$127.4M -$83.56M -$43.66M -$19.18M -$13.68M
EBITDA -$103.3M -$141.6M -$169.4M -$127.1M -$83.50M -$43.46M -$18.75M -$13.25M
Interest Income $3.96M $9.37M $10.65M $4.28M $91K -- -- --
Interest Expense $1.60M $1.73M $1.56M $238K $13K -- -- --
Income Before Tax -$101.7M -$134.8M -$160.8M -$123.4M -$83.48M -$45.50M -$19.21M -$13.69M
Income Tax Expense $0 $0 $0 $64K -$21K $241K $34K $45K
Net Income -$101.7M -$134.8M -$160.8M -$123.5M -$83.46M -$45.74M -$19.24M -$13.73M
Basic EPS -$1.90 -$2.58 -$3.74 -$3.03 -$2.07 -$2.76 -$7.56 -$6.33
Diluted EPS -$1.90 -$2.58 -$3.74 -$3.03 -$2.07 -$2.76 -$7.56 -$6.33
Basic Shares Outstanding 53.7M 52.2M 43.0M 40.7M 40.3M 18.5M 3.1M 2.8M
Diluted Shares Outstanding 53.7M 52.2M 43.0M 40.7M 40.3M 18.5M 3.1M 2.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $17.46M $13.14M $13.61M $17.64M $17.44M $18.02M $23.89M $23.53M
Total Operating Expenses $22.95M $18.03M $18.97M $23.02M $22.53M $26.65M $31.82M $30.61M
Operating Income -$22.95M -$18.03M -$18.97M -$23.02M -$22.53M -$26.65M -$31.82M -$30.61M
EBITDA -$22.89M -$17.95M -$18.82M -$22.87M -$22.38M -$26.46M -$31.61M -$30.40M
Interest Income $1.38M $1.51M $1.18M $573K $802K $1.11M $1.48M $1.88M
Interest Expense $225K $285K $331K $383K $408K $405K $406K $427K
Net Income -$21.83M -$17.97M -$17.93M -$22.85M -$22.14M -$25.95M -$30.75M -$29.16M
Basic EPS -$0.15 -$0.13 -$0.17 -- -$0.41 -$0.49 -$0.58 --
Diluted EPS -$0.15 -$0.13 -$0.17 -- -$0.41 -$0.49 -$0.58 --
Basic Shares Outstanding 140.9M 135.6M 104.6M -- 53.6M 53.4M 53.4M --
Diluted Shares Outstanding 140.9M 135.6M 104.6M -- 53.6M 53.4M 53.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $16.37M $17.57M $22.41M $48.82M $363.7M $434.2M $9.02M
Short-Term Investments $28.42M $110.2M $160.3M $217.4M -- -- --
Cash & Short-Term Investments $44.79M $127.8M $182.7M $266.2M $363.7M $434.2M $9.02M
Other Current Assets $20K $27K $439K -- -- -- --
Total Current Assets $50.73M $134.4M $188.7M $271.0M $367.0M $436.0M $9.81M
Property, Plant & Equipment, Net $1.20M $2.90M $3.59M $3.89M $897K $52K $860K
Long-Term Investments $3.49M $3.52M $35.41M $16.70M -- -- --
Other Non-Current Assets $3.62M $6.99M $14.89M $14.93M $12.27M $10K $7.0K
Total Non-Current Assets $8.32M $13.42M $53.89M $35.52M $13.16M $62K $867K
Total Assets $59.05M $147.8M $242.6M $306.5M $380.2M $436.1M $10.68M
Accounts Payable $4.91M $4.50M $8.59M $8.07M $3.76M $4.0K $3.75M
Short-Term Debt $5.22M $435K $0 $0 -- -- --
Other Current Liabilities $0 $149K $543K $1.65M -- -- --
Total Current Liabilities $24.55M $18.50M $36.00M $28.32M $15.29M $6.20M $4.98M
Long-Term Debt $4.53M $9.47M $9.64M $9.39M -- -- $5.42M
Other Non-Current Liabilities $3.98M $6.19M $7.20M $5.31M $1.84M $5.0K $547K
Total Non-Current Liabilities $8.51M $15.66M $16.84M $14.70M $1.84M $5.0K $5.97M
Total Liabilities $33.06M $34.16M $52.84M $43.02M $17.13M $6.21M $10.95M
Total Debt (incl. Leases) $14.77M $16.98M $17.20M $15.70M $2.72M -- $5.42M
Common Stock $54K $53K $50K $41K $41K $40K $3.0K
Retained Earnings -$722.8M -$621.1M -$486.3M -$325.5M -$202.0M -$118.5M -$72.78M
Accumulated Other Comp. Income $28K $275K $256K -$845K -- -- --
Total Stockholders' Equity $25.98M $113.6M $189.7M $263.5M $363.0M $429.8M -$70.64M
Total Equity $25.98M $113.6M $189.7M $263.5M $363.0M $429.8M -$70.64M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $35.45M $22.69M $32.28M $16.37M $23.44M $19.30M $20.61M $17.57M
Short-Term Investments $111.8M $115.5M $108.0M $28.42M $37.18M $60.01M $77.22M $110.2M
Cash & Short-Term Investments $147.2M $138.2M $140.3M $44.79M $60.63M $79.31M $97.83M $127.8M
Other Current Assets $132K $542K $25K $20K -- $4.0K -- $27K
Total Current Assets $152.9M $143.5M $145.6M $50.73M $66.52M $85.26M $102.5M $134.4M
Property, Plant & Equipment, Net $149K $166K $1.05M $1.20M $1.35M $1.50M $2.70M $2.90M
Long-Term Investments $0 $15.15M $28.78M $3.49M $5.84M $4.23M $9.16M $3.52M
Other Non-Current Assets $1.66M $2.05M $2.93M $3.62M $9.02M $4.33M $6.50M $6.99M
Total Non-Current Assets $1.80M $17.36M $32.76M $8.32M $16.21M $10.06M $18.37M $13.42M
Total Assets $154.7M $160.8M $178.3M $59.05M $82.72M $95.32M $120.9M $147.8M
Accounts Payable $3.99M $3.02M $3.85M $4.91M $6.58M $4.90M $3.94M $4.50M
Short-Term Debt $0 $0 $5.22M $5.22M $4.35M $3.04M $1.74M $435K
Other Current Liabilities -- -- -- $0 $0 $40K $48K $149K
Total Current Liabilities $19.02M $14.78M $20.18M $24.55M $27.72M $18.85M $18.74M $18.50M
Long-Term Debt $9.74M $9.71M $3.29M $4.53M $5.76M $7.00M $8.23M $9.47M
Other Non-Current Liabilities $64K $152K $3.51M $3.98M $4.44M $5.06M $5.63M $6.19M
Total Non-Current Liabilities $9.80M $9.86M $6.80M $8.51M $10.20M $12.06M $13.86M $15.66M
Total Liabilities $28.82M $24.63M $26.98M $33.06M $37.92M $30.91M $32.60M $34.16M
Total Debt (incl. Leases) $10.70M $11.04M $13.05M $14.77M $15.61M $16.18M $16.59M $16.98M
Common Stock $143K $138K $135K $54K $54K $54K $53K $53K
Retained Earnings -$780.5M -$758.7M -$740.7M -$722.8M -$700.0M -$677.8M -$651.9M -$621.1M
Accumulated Other Comp. Income -$259K -$224K -$245K $28K $43K $36K $118K $275K
Total Stockholders' Equity $125.9M $136.2M $151.3M $25.98M $44.80M $64.42M $88.30M $113.6M
Total Equity $125.9M $136.2M $151.3M $25.98M $44.80M $64.42M $88.30M $113.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$101.7M -$134.8M -$160.8M -$123.5M -$83.46M -$45.74M -$19.24M -$13.73M
Depreciation & Amortization $706K $872K $836K $342K $51K $202K $429K $431K
Stock-Based Compensation $12.58M $27.09M $26.27M $23.84M $13.91M $5.44M $297K $269K
Change in Payables $421K -$4.02M $458K $4.51M $3.29M -$3.74M $2.98M -$269K
Operating Cash Flow -$84.14M -$121.9M -$130.4M -$89.22M -$68.10M -$38.29M -$14.25M -$13.19M
Capital Expenditure -$212K -$447K -$1.27M -$1.43M -$666K -$31K -$353K -$653K
Free Cash Flow -$84.35M -$122.4M -$131.6M -$90.65M -$68.77M -$38.32M -$14.60M -$13.84M
Purchases of Investments -$51.59M -$107.4M -$246.6M -$376.8M -- -- -- --
Investing Cash Flow $82.59M $86.26M $44.66M -$235.4M -$4.92M $610K -$353K -$653K
Common Stock Issued $1.69M $29.66M -- -- -- $368.3M -- --
Share Repurchases -- -- -- -- -- -- -- -$6.0K
Financing Cash Flow $362K $30.82M $59.29M $9.86M $2.47M $462.9M $15.36M $1.0K
Net Change in Cash -$1.19M -$4.84M -$26.42M -$314.8M -$70.55M $425.2M $755K -$13.84M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$21.83M -$17.97M -$17.93M -$22.85M -$22.14M -$25.95M -$30.75M -$29.16M
Depreciation & Amortization $56K $86K $150K $151K $153K $191K $211K $214K
Stock-Based Compensation $2.89M $2.68M $2.51M $2.71M $2.52M $2.14M $5.22M $5.86M
Change in Payables $1.05M -$765K -$1.21M -$1.67M $1.68M $965K -$556K -$3.39M
Operating Cash Flow -$14.74M -$16.06M -$18.65M -$18.98M -$17.09M -$23.41M -$24.66M -$32.05M
Capital Expenditure -$65K -$17K -$50K -$49K -$56K -$47K -$60K -$60K
Free Cash Flow -$14.80M -$16.07M -$18.70M -$19.03M -$17.15M -$23.45M -$24.72M -$32.11M
Purchases of Investments -$25.05M -$5.75M -$124.5M -$5.97M -$4.44M -$25.40M -$15.78M -$4.44M
Investing Cash Flow $19.24M $6.52M -$105.0M $11.23M $21.39M $22.32M $27.64M $33.18M
Common Stock Issued $8.54M $0 $11K $1.32M $0 $0 $372K $359K
Financing Cash Flow $8.20M $137K $139.6M $678K -$159K -$222K $65K $328K
Net Change in Cash $12.70M -$9.40M $15.91M -$7.07M $4.14M -$1.31M $3.05M $1.47M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -3694.0% -400.0% -662.0%
Net Profit Margin -- -- -- -- -- -3869.7% -401.2% -664.3%
Return on Equity (ROE) -391.4% -118.7% -84.8% -46.9% -23.0% -10.6% -- --
Return on Assets (ROA) -172.2% -91.3% -66.3% -40.3% -22.0% -10.5% -180.2% --
Current Ratio 2.07x 7.26x 5.24x 9.57x 24.00x 70.28x 1.97x --
Quick Ratio 1.82x 6.91x 5.08x 9.40x 23.78x 69.99x 1.81x --
Debt to Equity 0.57x 0.15x 0.09x 0.06x 0.01x -- -- --
Revenue Growth (YoY) -- -- -- -- -100.0% -75.4% +132.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -64.0% -59.4% -58.7% -391.4% -241.1% -181.0% -147.3% -118.7%
Return on Assets (ROA) -52.1% -50.3% -49.8% -172.2% -130.6% -122.3% -107.5% -91.3%
Current Ratio 8.04x 9.71x 7.21x 2.07x 2.40x 4.52x 5.47x 7.26x
Quick Ratio 7.74x 9.35x 6.95x 1.82x 2.19x 4.21x 5.22x 6.91x
Debt to Equity 0.09x 0.08x 0.09x 0.57x 0.35x 0.25x 0.19x 0.15x
Source: SEC EDGAR CompanyFacts (CIK 0001810182) · from December 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:46 UTC · Open in terminal